Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP 3 /CaMK I/CREB pathway
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Cholangiopathies are characterized by the heterogeneous proliferation of different-sized cholangiocytes. Large cholangiocytes proliferate by a cAMP-dependent mechanism. The function of small cholangiocytes may depend on the activation of inositol trisphosphate (IP 3 )/Ca 2+ -dependent signaling pathways; however, data supporting this speculation are lacking. Four histamine receptors exist (HRH1, HRH2, HRH3, and HRH4). In several cells: 1) activation of HRH1 increases intracellular Ca 2+ concentration levels; and 2) increased [Ca 2+ ] i levels are coupled with calmodulin-dependent stimulation of calmodulin-dependent protein kinase (CaMK) and activation of cAMP-response element binding protein (CREB). HRH1 agonists modulate small cholangiocyte proliferation by activation of IP 3 /Ca 2+ -dependent CaMK/CREB. We evaluated HRH1 expression in cholangiocytes. Small and large cholangiocytes were stimulated with histamine trifluoromethyl toluidide (HTMT dimaleate; HRH1 agonist) for 24–48 h with/without terfenadine, BAPTA/AM, or W7 before measuring proliferation. Expression of CaMK I, II, and IV was evaluated in small and large cholangiocytes. We measured IP 3 , Ca 2+ and cAMP levels, phosphorylation of CaMK I, and activation of CREB (in the absence/presence of W7) in small cholangiocytes treated with HTMT dimaleate. CaMK I knockdown was performed in small cholangiocytes stimulated with HTMT dimaleate before measurement of proliferation and CREB activity. Small and large cholangiocytes express HRH1, CaMK I, and CaMK II. Small (but not large) cholangiocytes proliferate in response to HTMT dimaleate and are blocked by terfenadine (HRH1 antagonist), BAPTA/AM, and W7. In small cholangiocytes, HTMT dimaleate increased IP 3 /Ca 2+ levels, CaMK I phosphorylation, and CREB activity. Gene knockdown of CaMK I ablated the effects of HTMT dimaleate on small cholangiocyte proliferation and CREB activation. The IP 3 /Ca 2+ /CaMK I/CREB pathway is important in the regulation of small cholangiocyte function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wayman, G. A., Impey, S., Marks, D., Saneyoshi, T., Grant, W. F., Derkach, V., & Soderling, T. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.05.008 · Cited by 466
Cited by
The Inositol Trisphosphate/Calcium Signaling Pathway in Health and Disease
Berridge, M. J. (2016) · Physiological Reviews · doi:10.1152/physrev.00006.2016 · Cited by 753
Maia, L. B., & Moura, J. J. G. (2014) · Chemical Reviews · doi:10.1021/cr400518y · Cited by 401
Organotypic liver culture models: meeting current challenges in toxicity testing
LeCluyse, E. L., Witek, R. P., Andersen, M. E., & Powers, M. J. (2012) · Critical Reviews in Toxicology · doi:10.3109/10408444.2012.682115 · Cited by 363
Quinn, M., McMillin, M., Galindo, C., Frampton, G., Pae, H. Y., & DeMorrow, S. (2014) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.01.159 · Cited by 259
Krasner, N. M., Ido, Y., Ruderman, N. B., & Cacicedo, J. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097554 · Cited by 186
“Thus, it is noteworthy that liraglutide increased the phosphorylation of CREB at Ser 133, a known target of CaMKI [37] (Figure 4E, see also Figure 7).”
BackgroundMethodComplex bile duct network formation within liver decellularized extracellular matrix hydrogels
Lewis, P. L., Su, J., Yan, M., Meng, F., Glaser, S. S., Alpini, G. D., Green, R. M., Sosa-Pineda, B., & Shah, R. N. (2018) · Scientific Reports · doi:10.1038/s41598-018-30433-6 · Cited by 68
Self-citationDirecting the growth and alignment of biliary epithelium within extracellular matrix hydrogels
Lewis, P. L., Yan, M., Su, J., & Shah, R. N. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.12.039 · Cited by 61
Woo, K., Sathe, M., Kresge, C., Esser, V., Ueno, Y., Venter, J., Glaser, S. S., Alpini, G., & Feranchak, A. P. (2010) · Hepatology · doi:10.1002/hep.23883 · Cited by 54
“Conversely, small cholangiocytes, from small ducts, do not express secretin receptors, CFTR, or HCO3 /Cl exchanger and do not exhibit a secretory response to secretin.(3) In human liver, parallel to the findings observed in the rat and mouse, secretinstimulated duct secretory activity is heterogeneous, because only me…”
BackgroundMethodSelf-citationTabibian, J. H., Masyuk, A. I., Masyuk, T. V., O'Hara, S. P., & LaRusso, N. F. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00495.x · Cited by 52
“…mitotically dormant, may proliferate in response to various (e.g., histamine, secretin, α -naphthylisothiocyanate, acute carbon tetrachloride) (90,93,105,107,165,196,207) insults (e.g., partial hepatectomy) (9, 179) and acquire features of large cholangiocytes (92,104,171,179). proliferation…”
Metadata
- Authors
- Francis, H., Glaser, S., DeMorrow, S., Gaudio, E., Ueno, Y., Venter, J., Dostal, D., Onori, P., Franchitto, A., Marzioni, M., Vaculin, S., Vaculin, B., Katki, K., Stutes, M., Savage, J., & Alpini, G.
- Venue
- American Journal of Physiology-Cell Physiology
- Publisher
- American Physiological Society
- Published
- 2008-08
- Volume
- 295
- Issue
- 2
- Pages
- C499-C513
- ISSN
- 0363-6143 (ISSN-L)
- 1522-1563
- OpenAlex
- W1982708256
- Cited by
- 136
- References
- 1
- FWCI
- 8.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.